Literature DB >> 29625051

Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation.

Tathiane M Malta1, Artem Sokolov2, Andrew J Gentles3, Tomasz Burzykowski4, Laila Poisson5, John N Weinstein6, Bożena Kamińska7, Joerg Huelsken8, Larsson Omberg9, Olivier Gevaert3, Antonio Colaprico10, Patrycja Czerwińska11, Sylwia Mazurek12, Lopa Mishra13, Holger Heyn14, Alex Krasnitz15, Andrew K Godwin16, Alexander J Lazar6, Joshua M Stuart17, Katherine A Hoadley18, Peter W Laird19, Houtan Noushmehr20, Maciej Wiznerowicz21.   

Abstract

Cancer progression involves the gradual loss of a differentiated phenotype and acquisition of progenitor and stem-cell-like features. Here, we provide novel stemness indices for assessing the degree of oncogenic dedifferentiation. We used an innovative one-class logistic regression (OCLR) machine-learning algorithm to extract transcriptomic and epigenetic feature sets derived from non-transformed pluripotent stem cells and their differentiated progeny. Using OCLR, we were able to identify previously undiscovered biological mechanisms associated with the dedifferentiated oncogenic state. Analyses of the tumor microenvironment revealed unanticipated correlation of cancer stemness with immune checkpoint expression and infiltrating immune cells. We found that the dedifferentiated oncogenic phenotype was generally most prominent in metastatic tumors. Application of our stemness indices to single-cell data revealed patterns of intra-tumor molecular heterogeneity. Finally, the indices allowed for the identification of novel targets and possible targeted therapies aimed at tumor differentiation.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  The Cancer Genome Atlas; cancer stem cells; dedifferentiation; epigenomic; genomic; machine learning; pan-cancer; stemness

Mesh:

Substances:

Year:  2018        PMID: 29625051      PMCID: PMC5902191          DOI: 10.1016/j.cell.2018.03.034

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  491 in total

1.  Biomaterial Scaffolds Recruit an Aggressive Population of Metastatic Tumor Cells In Vivo.

Authors:  Grace G Bushnell; Tejaswini P Hardas; Rachel M Hartfield; Yining Zhang; Robert S Oakes; Scott Ronquist; Haiming Chen; Indika Rajapakse; Max S Wicha; Jacqueline S Jeruss; Lonnie D Shea
Journal:  Cancer Res       Date:  2019-02-26       Impact factor: 12.701

Review 2.  A systems approach to clinical oncology uses deep phenotyping to deliver personalized care.

Authors:  James T Yurkovich; Qiang Tian; Nathan D Price; Leroy Hood
Journal:  Nat Rev Clin Oncol       Date:  2019-10-16       Impact factor: 66.675

3.  Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia.

Authors:  Michael Y Choi; George F Widhopf; Emanuela M Ghia; Reilly L Kidwell; Md Kamrul Hasan; Jian Yu; Laura Z Rassenti; Liguang Chen; Yun Chen; Emily Pittman; Minya Pu; Karen Messer; Charles E Prussak; Januario E Castro; Catriona Jamieson; Thomas J Kipps
Journal:  Cell Stem Cell       Date:  2018-06-01       Impact factor: 24.633

Review 4.  DNA damage in aging, the stem cell perspective.

Authors:  Taylor McNeely; Michael Leone; Hagai Yanai; Isabel Beerman
Journal:  Hum Genet       Date:  2019-07-19       Impact factor: 4.132

Review 5.  MUC1-C in chronic inflammation and carcinogenesis; emergence as a target for cancer treatment.

Authors:  Donald W Kufe
Journal:  Carcinogenesis       Date:  2020-09-24       Impact factor: 4.944

6.  Cancer stem cell-associated miRNAs serve as prognostic biomarkers in colorectal cancer.

Authors:  Shusuke Toden; Shigeyasu Kunitoshi; Jacob Cardenas; Jinghua Gu; Elizabeth Hutchins; Kendall Van Keuren-Jensen; Hiroyuki Uetake; Yuji Toiyama; Ajay Goel
Journal:  JCI Insight       Date:  2019-03-21

7.  Metformin Inhibits Progression of Head and Neck Squamous Cell Carcinoma by Acting Directly on Carcinoma-Initiating Cells.

Authors:  Xingyu Wu; Huwate Yeerna; Yusuke Goto; Toshinori Ando; Victoria H Wu; Xuefeng Zhang; Zhiyong Wang; Panomwat Amornphimoltham; Anne N Murphy; Pablo Tamayo; Qianming Chen; Scott M Lippman; J Silvio Gutkind
Journal:  Cancer Res       Date:  2019-07-10       Impact factor: 12.701

Review 8.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

Review 9.  Environmental exposures, stem cells, and cancer.

Authors:  Tasha Thong; Chanese A Forté; Evan M Hill; Justin A Colacino
Journal:  Pharmacol Ther       Date:  2019-07-31       Impact factor: 12.310

10.  Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy.

Authors:  Karsten Krug; Eric J Jaehnig; Shankha Satpathy; Lili Blumenberg; Alla Karpova; Meenakshi Anurag; George Miles; Philipp Mertins; Yifat Geffen; Lauren C Tang; David I Heiman; Song Cao; Yosef E Maruvka; Jonathan T Lei; Chen Huang; Ramani B Kothadia; Antonio Colaprico; Chet Birger; Jarey Wang; Yongchao Dou; Bo Wen; Zhiao Shi; Yuxing Liao; Maciej Wiznerowicz; Matthew A Wyczalkowski; Xi Steven Chen; Jacob J Kennedy; Amanda G Paulovich; Mathangi Thiagarajan; Christopher R Kinsinger; Tara Hiltke; Emily S Boja; Mehdi Mesri; Ana I Robles; Henry Rodriguez; Thomas F Westbrook; Li Ding; Gad Getz; Karl R Clauser; David Fenyö; Kelly V Ruggles; Bing Zhang; D R Mani; Steven A Carr; Matthew J Ellis; Michael A Gillette
Journal:  Cell       Date:  2020-11-18       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.